Methoxsalen

甲氧沙林

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMethoxsalen
Drug Alias NameXanthotoxin速克萨林花椒毒素Ammoidin甲氧补骨脂素 +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA cross linking agentsPhotosensitizers
TargetsDNA
Therapy Area/IndicationsGraft vs Host DiseasePsoriasisVitiligo +[10] 
Global Approved IndicationsPsoriasisVitiligoLymphoma, T-Cell, Cutaneous
Approved Indications in ChinaPsoriasisVitiligo
Original Approved Country/TerritoryUnited States
Original Approved Date1954/12/03
Country/TerritoryBelgiumCanadaUnited States +[19] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesValeant
China Registration ClassN/A

Develop Information

Active CompaniesWashington University School Of MedicineColumbia UniversityWuhan Wuyao Pharmaceutical Co Ltd +[4] 
Inactive CompaniesTherakos IncTherakos LLCNational Cancer Institute +[8] 
Active IndicationsPsoriasisVitiligoMycosis Fungoides +[4] 
Inactive IndicationsGraft vs Host DiseaseEpidermolysis Bullosa AcquisitaCrohn Disease +[6] 

Other Information

ATC CodeD05AD02D05BA02
Related LinksWikipediaDrugBankKEGG